Antibodies specific for human CD22 and their therapeutic and diagnostic use

• 收藏
• 分享

专利权人:

UCB Pharma; S.A.

发明人:

申请号：

LTPA2017043

公开号：

LTPA2017043I1

申请日:

2017.12.21

申请国别(地区):

LT

年份:

2018

代理人:

摘要：

There is disclosed antibody molecules containing at least one CDR derived from a mouse monoclonal antibody having specificity for human CD22. There is also disclosed a CDR grafted antibody wherein at least one of the CDRs is a modified CDR. Further disclosed are DNA sequences encoding the chains of the antibody molecules, vectors, transformed host cells and uses of the antibody molecules in the treatment of diseases mediated by cells expressing CD22.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/